582 related articles for article (PubMed ID: 17599072)
21. Dealing with death: HMGB1 as a novel target for cancer therapy.
Lotze MT; DeMarco RA
Curr Opin Investig Drugs; 2003 Dec; 4(12):1405-9. PubMed ID: 14763124
[TBL] [Abstract][Full Text] [Related]
22. Insight into the mechanisms regulating immune homeostasis in health and disease.
Sirisinha S
Asian Pac J Allergy Immunol; 2011 Mar; 29(1):1-14. PubMed ID: 21560483
[TBL] [Abstract][Full Text] [Related]
23. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity.
Castiglioni A; Canti V; Rovere-Querini P; Manfredi AA
Cell Tissue Res; 2011 Jan; 343(1):189-99. PubMed ID: 20835834
[TBL] [Abstract][Full Text] [Related]
24. Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases.
Schaefer L
Curr Opin Pharmacol; 2010 Apr; 10(2):185-90. PubMed ID: 20045380
[TBL] [Abstract][Full Text] [Related]
25. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.
Bianchi ME; Manfredi AA
Immunol Rev; 2007 Dec; 220():35-46. PubMed ID: 17979838
[TBL] [Abstract][Full Text] [Related]
26. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
[TBL] [Abstract][Full Text] [Related]
27. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation.
Foell D; Frosch M; Sorg C; Roth J
Clin Chim Acta; 2004 Jun; 344(1-2):37-51. PubMed ID: 15149869
[TBL] [Abstract][Full Text] [Related]
28. DAMPs, PAMPs and alarmins: all we need to know about danger.
Bianchi ME
J Leukoc Biol; 2007 Jan; 81(1):1-5. PubMed ID: 17032697
[TBL] [Abstract][Full Text] [Related]
29. RAGE in inflammation: a new therapeutic target?
Bierhaus A; Stern DM; Nawroth PP
Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
[TBL] [Abstract][Full Text] [Related]
30. Nod-like proteins in inflammation and disease.
Carneiro LA; Magalhaes JG; Tattoli I; Philpott DJ; Travassos LH
J Pathol; 2008 Jan; 214(2):136-48. PubMed ID: 18161746
[TBL] [Abstract][Full Text] [Related]
31. TREM-1, HMGB1 and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis.
Thankam FG; Dilisio MF; Dietz NE; Agrawal DK
PLoS One; 2016; 11(10):e0165492. PubMed ID: 27792788
[TBL] [Abstract][Full Text] [Related]
32. Sensing danger--Hsp72 and HMGB1 as candidate signals.
Williams JH; Ireland HE
J Leukoc Biol; 2008 Mar; 83(3):489-92. PubMed ID: 18156188
[TBL] [Abstract][Full Text] [Related]
33. High-mobility group box-1 in sterile inflammation.
Tsung A; Tohme S; Billiar TR
J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
[TBL] [Abstract][Full Text] [Related]
34. [Innate immunity, receptors for exogenous and endogenous danger patterns in immunopathogenesis of atherosclerosis--part 1: identification of danger signals by innate immunity].
Krejsek J; Kunes P; Andrýs C; Holická M; Novosad J; Kudlová M; Kolácková M
Cas Lek Cesk; 2005; 144(12):785-9. PubMed ID: 16389747
[TBL] [Abstract][Full Text] [Related]
35. Extracellular heat shock proteins in cell signaling.
Calderwood SK; Mambula SS; Gray PJ; Theriault JR
FEBS Lett; 2007 Jul; 581(19):3689-94. PubMed ID: 17499247
[TBL] [Abstract][Full Text] [Related]
36. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
[TBL] [Abstract][Full Text] [Related]
37. Monosodium urate crystals in inflammation and immunity.
Shi Y; Mucsi AD; Ng G
Immunol Rev; 2010 Jan; 233(1):203-17. PubMed ID: 20193001
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptors in inflammation, infection and cancer.
Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
[TBL] [Abstract][Full Text] [Related]
39. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
40. Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects.
Alvarez-Pellitero P
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):171-98. PubMed ID: 18783835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
